Calcium Levofolinate

• Study evaluating two treatment strategies for rectal cancer in patients ≥75 years old Pending
  2025-521619-37-00 Phase III 1 country Unicancer
• ENGIC 02 - PRODIGE 86-FOLFIRINOX SBA- Phase II randomized trial evaluating modified FOLFIRINOX and FOLFOX in the treatment of locally advanc… Recruiting
  2023-505486-92-00 Phase II 2 countries Centre Hospitalier Universitaire De Dijon
• Testing ivonescimab in combination with standard chemotherapy in advanced or metastatic gastric and gastroesophageal adenocarcinoma patients Recruiting
  2025-520694-39-00 Phase II 1 country Unicancer
• Regorafenib as second-line treatment of patients with RAS-mutant advanced colorectal cancer: a multicentre, phase 2 study - STREAM-2 Recruiting
  2024-519669-23-00 Phase II 1 country IRCCS Istituto Nazionale Tumori Fondazione Pascale
• Testing ivonescimab versus FOLFOX in advanced biliary tract cancer patients Recruiting
  2024-515875-36-00 Phase II 1 country Unicancer
• CAPRI-3 Phase 3 clinical study to evaluate the use of continuing cetuximab treatment beyond first line progression in molecular selected met… Recruiting
  2024-519322-20-00 Phase III 2 countries Gruppo Oncologico Dell'Italia Meridionale
• metastatic colorectal cancer Recruiting
  2023-504831-42-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• Prospective phase IIb study to evaluate the efficacy of laparoscopic electrochemotherapy in the treatment of locally advanced pancreatic can… Recruiting
  2024-519067-17-00 Phase II 1 country IRCCS Istituto Nazionale Tumori Fondazione Pascale
• A personalised approach based on blood and tumor characteristics to guide the post-surgical clinical path of patients with operable locoregi… Recruiting
  2023-509851-15-00 Phase III 3 countries Ifom Istituto Fondazione Di Oncologia Molecolare Ets In Breve Ifom Ets
• Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: … Recruiting
  2024-515981-14-00 Phase III 1 country Azienda Ospedaliera Universitaria Integrata Verona
• Investigate the efficacy and safety of a bio-marker driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with RA… Recruiting
  2024-518534-81-00 Phase II 1 country Gruppo Oncologico Dell'Italia Meridionale
• GASTRICHIP TRIAL. D2 resection and HIPEC (Hyperthermic IntraPeritoneal Chemoperfusion) in locally advanced gastric carcinoma. Recruiting
  2024-516358-23-00 Phase III 1 country Hospices Civils De Lyon
• The study aims to verify the greater efficacy of the treatment of Acute Lymphoblastic Leukemia Ph + through the combination of Ponatinib and… Ended
  2023-508968-30-00 Phase III 1 country Fondazione Gimema Franco Mandelli Onlus
• Comparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorectal Cancer Patients (PANIRINOX) Ended
  2024-510645-34-00 Phase II 1 country Unicancer
• A Phase 2, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination With Bevacizumab and FOLFIRI Versus … Ended
  2022-500177-13-00 Phase II 5 countries Gilead Sciences Inc.
• Phase III randomised trial evaluating FOLFOX with or without DOCETAXEL (TFOX) as 1st line chemotherapy for locally advanced or metastatic oe… Ended
  2024-515221-29-00 Phase II/III 1 country Fondation Franc.Cancerologie Digestive

Showing 1–16 of 16 trials